ZNF493 engage distinct cellular signaling pathways to modulate the protein's activity. Phorbol 12-myristate 13-acetate (PMA) and 1,2-Dioctanoyl-sn-glycerol (DiC8), both function as activators of protein kinase C (PKC). PKC, upon activation, targets a variety of proteins through phosphorylation, which can lead to the activation of ZNF493. Similarly, Forskolin, by increasing intracellular levels of cAMP, activates protein kinase A (PKA), another kinase that can phosphorylate associated regulatory proteins, thereby influencing ZNF493 activity. Ionomycin, by increasing intracellular calcium levels, can activate calcium-dependent kinases such as calmodulin-dependent kinase (CaMK), which then may phosphorylate proteins that modulate ZNF493 activity. Epidermal Growth Factor (EGF) works through its receptor to initiate a cascade that includes the MAPK/ERK pathway, potentially leading to phosphorylation events that enhance the function of ZNF493.
Insulin activation of its receptor sets off multiple pathways, including the PI3K/Akt pathway, where Akt can phosphorylate a range of substrates that have the capacity to interact with or modify the activity of ZNF493. Okadaic Acid and Calyculin A, both inhibitors of protein phosphatases PP1 and PP2A, lead to an increase in the phosphorylation levels of cellular proteins, which can include those that regulate ZNF493, resulting in its activation. Sodium Orthovanadate acts as a general phosphatase inhibitor, maintaining proteins in a phosphorylated state, which can affect the activity state of ZNF493. Anisomycin activates stress-activated protein kinases, which may phosphorylate regulatory proteins linked to ZNF493. Phosphatidic acid, serving as a second messenger, can activate mTOR signaling, which may lead to the phosphorylation of proteins that regulate ZNF493. Lastly, Bryostatin 1 modulates PKC, potentially leading to phosphorylation of proteins in the regulatory network of ZNF493, influencing its activity.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA directly activates protein kinase C (PKC), which is a known regulator of a multitude of signaling pathways including those that lead to transcription factor activation. ZNF493, being a zinc finger protein, may have its DNA binding activity regulated by phosphorylation events mediated by PKC, resulting in its functional activation. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore which increases intracellular calcium levels that can activate calmodulin-dependent kinase (CaMK), which may phosphorylate proteins associated with ZNF493, influencing its activity and promoting its functional activation. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Insulin receptor activation stimulates multiple signaling pathways, including PI3K/Akt pathway. Akt can phosphorylate various substrates that may interact with or modify the activity of ZNF493, leading to its functional activation. | ||||||
1,2-Dioctanoyl-sn-glycerol | 60514-48-9 | sc-202397 sc-202397A | 10 mg 50 mg | $47.00 $254.00 | 2 | |
DiC8 is a synthetic analogue of diacylglycerol (DAG) and acts as a PKC activator. By activating PKC, DiC8 can influence proteins that regulate ZNF493, thereby promoting its functional activation. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic acid is a potent inhibitor of protein phosphatases PP1 and PP2A, leading to increased phosphorylation levels of cellular proteins. This can enhance the activity of proteins that regulate ZNF493, resulting in its activation. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is a protein synthesis inhibitor that also activates stress-activated protein kinases (SAPKs) like JNK. Activation of JNK pathway may lead to the phosphorylation of regulatory proteins that could enhance ZNF493 activity. | ||||||
Sodium Orthovanadate | 13721-39-6 | sc-3540 sc-3540B sc-3540A | 5 g 10 g 50 g | $49.00 $57.00 $187.00 | 142 | |
Sodium Orthovanadate is a phosphatase inhibitor that prevents dephosphorylation of proteins, potentially leading to enhanced phosphorylation status of proteins involved in the regulation of ZNF493, thus activating it. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Calyculin A is another inhibitor of protein phosphatases, specifically PP1 and PP2A. By inhibiting dephosphorylation, it may increase phosphorylation of proteins that are part of the regulatory network of ZNF493, leading to its activation. | ||||||
Bryostatin 1 | 83314-01-6 | sc-201407 | 10 µg | $245.00 | 9 | |
Bryostatin 1 binds to and modulates PKC, which could result in the phosphorylation of proteins that are part of the ZNF493 regulatory network, thus influencing ZNF493 activation. | ||||||